Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.51 |
| ▸ | FEN1 | P39748 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 9/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21656824 | 0.97 | LMNA (0.54) | LMNAALOX5APFEN1POLBP2RX3 | |
| SCHEMBL21656826 | 0.96 | LMNA (0.53) | LMNAALOX5APFEN1POLBP2RX3 | |
| SCHEMBL21656975 | 0.96 | LMNA (0.53) | LMNAALOX5APFEN1POLBP2RX3 | |
| SCHEMBL21656531 | 0.95 | LMNA (0.56) | LMNAALOX5APFEN1POLBP2RX3 | |
| SCHEMBL21656868 | 0.87 | PDE4B (0.53) | LMNAPOLBSMN1; SMN2HRH3ALDH1A1 | |
| SCHEMBL21628672 | 0.86 | HRH3 (0.59) | POLBSMN1; SMN2HRH3KCNH2HAO1 | |
| SCHEMBL21656821 | 0.86 | ALOX5AP (0.48) | ALOX5APFEN1POLBSMN1; SMN2HRH3 | |
| SCHEMBL21628427 | 0.85 | HDAC8 (0.57) | POLBSMN1; SMN2HRH3KCNH2HAO1 | |
| SCHEMBL21628590 | 0.85 | HRH3 (0.56) | HRH3KCNH2HAO1 | |
| SCHEMBL21656805 | 0.84 | ALDH1A1 (0.54) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885ALOX5AP 3143/4885FEN1 4361/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | LMNA 3083/4885ALOX5AP 3337/4885FEN1 4128/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885ALOX5AP 3143/4885FEN1 4361/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | LMNA 832/4885ALOX5AP 3839/4885FEN1 1122/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885ALOX5AP 3143/4885FEN1 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.